http://jcps.bjmu.edu.cn

• 研究论文 • 上一篇    下一篇

手性高效液相色谱法测定萘哌地尔对映异构体

孙银香, 黄碧云, 袁牧*, 石京山
  

  1. 1. 广州医学院 药物研究中心, 广东 广州 510182
    2. 遵义医学院 药理学教研室, 贵州 遵义 563003
  • 收稿日期:2008-09-04 修回日期:2009-02-10 出版日期:2009-03-15 发布日期:2009-03-15
  • 通讯作者: 袁牧*

Development of a chiral HPLC method for the analysis of naftopidil enantiomers

Yin-Xiang Sun, Bi-Yun Huang, Mu Yuan*, Jing-Shan Shi
  

  1. 1. The Pharmaceutical Research Center of Guangzhou Medical College, Guangzhou 510182, China
    2. The Pharmacology Department of Zunyi Medical College, Zunyi 563003, China
  • Received:2008-09-04 Revised:2009-02-10 Online:2009-03-15 Published:2009-03-15
  • Contact: Mu Yuan*

摘要: 建立一种手性高效液相色谱法分离与分析萘哌地尔对映异构体。采用AD-H (250 mm×4.6 mm, 5 μm)色谱柱, 检测波长为283 nm; 流动相为正己烷异丙醇三乙胺(85:15:0.1, v/v/v); 流速1.0 mL/min萘哌地尔对映体得到良好分离, R体和S体线性范围分别为0.78~50 μg/mL (r = 0.9999) 0.84~54 μg/mL (r = 0.9998), 相应的日内及日间精密度不高于0.5% 0.7%。本文报道了萘哌地尔对映异构体的分离及测定方法, 同时也可用于萘哌地尔合成对映体的纯度分析。

关键词: 对映体, 萘哌地尔, 手性高效液相色谱法, 分析

Abstract:

We developed a chiral HPLC method for the separation and analysis of naftopidil enantiomers. The two enantiomers of naftopidil were separated using a Chiralpak AD-H (250 mm×4.6 mm, 5 μm) column and monitored at the wavelength of 283 nm. The isocratic mobile phase consisting of hexane–isopropanol–diethylamine (85:15:0.1, v/v/v) was pumped at a flow rate of 1.0 mL/min. Under these chromatographic conditions, R-naftopidil and S-naftopidil were well separated and had good linearity in the ranges of 0.78–50 μg/mL (r = 0.9999) and 0.84–54 μg/mL (r = 0.9998), respectively. The relative standard deviations (RSD) of intra- and inter-day assays were no more than 0.5% and 0.7%, respectively. This improved method for the separation and quantitative determination of naftopidil enantiomers can be used for the quality control of synthesized naftopidil product.

Key words: Enantiomers, Enantiomers, Naftopidil, Naftopidil, Chiral HPLC, Chiral HPLC, Analysis, Analysis

中图分类号: 

Supporting: Foundation items: Guangzhou Science and Technology Projects of Apecial Areas of Innovative Medicines (Grant No.2006Z2-E4011), 2006 Guangdong Province Technology Projects (Grant No. 2006B35501003).
*Corresponding author. Tel./fax: 86-20-81340727